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alking and Sports Participation and
ortality From Coronary Heart Disease and Stroke
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OBJECTIVES We aimed to examine the impact of exercise on mortality from cardiovascular disease (CVD)
in Asian populations.
BACKGROUND Few data have been available in Asian countries, where job-related physical activity is higher
than that in Western countries.
METHODS Between 1988 and 1990, 31,023 men and 42,242 women in Japan, ages 40 to 79 years with
no history of stroke, coronary heart disease (CHD), or cancer, completed a self-administered
questionnaire. Systematic mortality surveillance was performed through 1999, and 1,946
cardiovascular deaths were identified. We chose the second lowest categories of walking and
sports participation as the reference to reduce a potential effect of ill health.
RESULTS Men and women who reported having physical activity in the highest category (i.e., walking
1 h/day or doing sports 5 h/week) had a 20% to 60% lower age-adjusted risk of mortality
from CVD, compared with those in the second lowest physical activity category (i.e., walking
0.5 h/day, or sports participation for 1 to 2 h/week). Adjustment for known risk factors,
exclusion of individuals who died within two years of baseline inquiry, or gender-specific
analysis did not substantially alter these associations. The multivariate-adjusted hazard ratios
(95% confidence interval) for the highest versus the second lowest categories of walking or
sports participation were 0.71 (0.54 to 0.94) and 0.80 (0.48 to 1.31), respectively, for ischemic
stroke (IS); 0.84 (0.64 to 1.09) and 0.51 (0.32 to 0.82), respectively, for CHD; and 0.84 (0.75
to 0.95) and 0.73 (0.60 to 0.90), respectively, for CVD.
CONCLUSIONS Physical activity through walking and sports participation might reduce the risk of mortality
from IS and CHD. (J Am Coll Cardiol 2005;46:1761–7) © 2005 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.038of Cardiology Foundation
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erevious prospective studies have shown an inverse associ-
tion between physical activity and the risk of developing
oronary heart disease (CHD) (1–4) and total or ischemic
troke (IS) (5–7) among whites and Japanese Americans.
From the *Department of Public Health Medicine, Doctoral Program in Social and
nvironmental Medicine, Graduate School of Comprehensive Human Sciences,
niversity of Tsukuba, Ibaraki; †Public Health, Department of Social and Environ-
ental Medicine, Osaka University, Graduate School of Medicine, Osaka; ‡Depart-
ent of Public Health/Health Information Dynamics, Fields of Science, Program of
ealth and Community Medicine, Nagoya University Graduate School of Medicine;
Department of Food Science and Nutrition, Faculty of Human Life and Environ-
ent, Nara Women’s University, Nara; Infectious Disease Surveillance Cancer,
nfectious Disease Research Division, Hyogo Prefectural Institute of Public Health
nd Environmental Science; ¶Department of Public Health, Aichi Medical Univer-
ity, Aichi; #Department of Health and Environmental Sciences, Graduate School of
edicine, Kyoto University; **Department of Social Medicine & Cultural Sciences,
esearch Institute for Neurological Diseases & Geriatrics, Kyoto Prefectural Univer-
ity of Medicine, Kyoto; and the ††Department of Hygiene, Hyogo College of
edicine, Hyogo; ‡‡Department of Epidemiology and Environmental Health,
chool of Medicine, Juntendo University, Tokyo; and the §§Department of Preven-
ive Medicine/Biostatistics and Medical Decision Making, Field of Social Science,
rogram in Health and Community Medicine, Nagoya University Graduate School
f Medicine, Nagoya, Japan. The Japan Collaborative Cohort Study for Evaluation
or Cancer Risk (JACC Study) has been supported by Grants-in-Aid for Scientific
esearch from the Ministry of Education, Science, Sports and Culture of Japan
Monbusho) (No. 61010076, 62010074, 63010074, 1010068, 2151065, 3151064,
151063, 5151069, 6279102 and 11181101).n
Manuscript received January 6, 2005; revised manuscript received June 13, 2005,
ccepted July 11, 2005.he benefits of physical activity include lowered blood
ressure (8,9), increased insulin sensitivity (10,11), elevated
DL-cholesterol levels (12), and improved endothelial
unction (13). To our knowledge, however, no prospective
tudy has reported these effects of exercise in Asian coun-
ries, where the prevalence of job-related physical activity
as been reported to be high (14).
In the current study we examined the relationship be-
ween physical activity through walking and sports partici-
ations and the mortality due to stroke, CHD, and total
ardiovascular disease (CVD) among Japanese men and
omen in a large cohort study.
ETHODS
tudy cohort and baseline questionnaire. The Japan Col-
aborative Cohort Study for Evaluation for Cancer Risk
JACC), sponsored by Ministry of Education, Science,
ports and Culture of Japan, was undertaken from 1988 to
990, when 110,792 individuals (46,465 men and 64,327
omen) ages 40 to 79 years and living in 45 communities
cross Japan participated in municipal health screening
xaminations and completed self-administered question-
aires about their lifestyles and medical histories of previous
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Exercise and Cardiovascular Disease November 1, 2005:1761–7VD and cancer (15). Informed consent was obtained from
ll subjects before completing the questionnaire. Of these
ubjects, 77,676 individuals (32,953 men and 44,723
omen) provided a valid response to questions about the
verage daily time spent walking: “How long on average do
ou spend walking indoors or outside on a daily basis?” The
ist of possible answers was: “0.5 h,” “0.5 h,” “0.6 to 0.9 h,”
nd “1.0 h.” Subjects were also questioned about the
verage weekly time spent in athletic and sporting events:
What is the average amount of time you spend engaging in
ports on a weekly basis?” The list of possible answers were:
1 h,” “1 to 2 h,” “3 to 4 h,” and “5 h.”
The validity of the estimated time spent participating in
ports and leisure time physical activity was examined in a
andom sample of 739 men and 991 women from the
aseline participants (16). The Spearman rank correlation
eported that time spent participating in sports with leisure-
ime physical activity as reported during the previous 12
onths, estimated from a structured interview on the basis
f the Minnesota leisure-time physical activity question-
aire (17), was 0.53 in men and 0.58 in women. The
eliability for time spent walking and engaging in sports was
xamined 12 months apart in a random sample of 416 men
nd 636 women. We obtained modest kappa coefficients:
.32 in men and 0.31 in women for time spent walking (four
ategories), and 0.45 in men and 0.40 in women for time
pent participating in sports (four categories).
We excluded 1,930 men and 2,481 women from the
nalysis because of a previous history of stroke, CHD, or
ancer at the time of baseline inquiry. Therefore, a total
3,265 individuals (31,023 men and 42,242 women) were
nrolled in the present study.
ortality surveillance. To find cohort deaths, the inves-
igators conducted a systematic review of death certificates,
ll of which were forwarded to the local public health center
n each community. It is believed all deaths that occurred in
he cohort were ascertained, except for subjects who died
fter they had moved from their original community, in
hich case the subject was treated as a censored case.
ortality data were sent centrally to the Ministry of Health
nd Welfare, and the underling causes of death were coded
or the National Vital Statistics according to the Interna-
ional Classification of Disease, 10th revision. The mortality
ollow-up inquiry for this study was conducted until the end
f 1999, and the average follow-up was 9.7 years. Only 3.4%
Abbreviations and Acronyms
CHD coronary heart disease
CI  confidence interval
CVD cardiovascular disease
HR  hazard ratio
IPH  intraparenchymal hemorrhage
IS  ischemic stroke
SAH  subarachnid hemorrhagef the subjects had moved out of the communities and were 2reated as censored. The Ethics Committee of the Univer-
ity of Tsukuba approved this study.
tatistical analysis. Statistical analysis was made on the
asis of cause-specific mortality rates. Person-years of
ollow-up were calculated from the date of the baseline
uestionnaire to the date of death, moving from the
ommunity, or the end of 1999, whichever occurred first.
he hazard ratio (HR) of mortality from CVD was defined
s the death rate for the participants within the four
ategories of walking time divided by the corresponding rate
mong those who reported 0.5 h/day of average walking
ime and for the participants within the four categories of
ports participation time divided by the corresponding rate
mong those who reported 1 to 2 h/week average time in
ports.
Age-adjusted means and proportions of selected cardio-
ascular risk factors were presented among the categories of
alking and sports participation. Differences from the
econd lowest category in gender-specific, age-adjusted
ean values and proportions of baseline characteristics were
xamined with a t test or chi-square test. The age-adjusted
nd multivariate-adjusted HRs and the 95% confidence
ntervals (CIs) were calculated after adjustment for age,
ender, and potential confounding factors with the Cox
roportional hazards model. These factors included body
ass index (gender-specific quintiles), history of hyperten-
ion (no versus yes), history of diabetes (no versus yes),
moking status (never, ex-smoker, and current smokers of 1
o 19 and 20 cigarettes/day), alcohol intake category
never, ex-drinker, and current drinker of ethanol at 1 to 22,
3 to 45, 46 to 68, and 69 g/day), hours of sleep (6.0,
.0 to 6.9, 7.0 to 7.9, 8.0 to 8.9, and 9.0 h/day), age of
ompleted education (13, 13 to 15, 16 to 18, and 19
ears old), job style (manual worker, non-manual worker,
nd non-worker), perceived mental stress (low, medium,
nd high), and frequency of fish intake (0, 1, 1 to 2, 3 to
, and 5 times/week). These factors had been known as
ardiovascular risk factors and associated with walking and
ports participation at baseline inquiry in this cohort. In the
nalysis of walking time, we also adjusted for time spent
articipating in sports, and in the analysis of sports partic-
pation, we adjusted for time spent walking.
Because the individuals in the lowest categories were
ore likely to have ill health and the goal of this study was
o study physical activity in healthy subjects, we chose the
econd lowest categories of walking and sports participation
s the reference.
Cause-specific mortality was determined by the total
eaths due to stroke (International Classification of Disease,
0th revision, codes I60 to 69), CHD (codes I20 to I25),
nd total CVD (codes I01 to I99). Stroke was further
ategorized as subarachnid hemorrhage (SAH) (code I60),
ntraparenchymal hemorrhage (IPH) (code I61), and IS
code I63). The analysis was repeated by excluding deaths
ithin the first two years after the baseline (476 men and
67 women), to examine the potential effect of any existing
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November 1, 2005:1761–7 Exercise and Cardiovascular Diseasere-clinical disorders that might have interfered with par-
icipation in walking and sports.
ESULTS
total of 73,265 individuals (31,023 men and 42,242
omen) were followed up for an average of 9.7 years, and
,946 subjects (1,081 men and 865 women) died from
VD. These deaths among men included a total of 499
rom stroke (127 IPH, 57 SAH, and 186 IS) and 244 from
HD. The number of deaths among women included a
otal of 424 from stroke (92 IPH, 98 SAH, and 141 IS) and
53 from CHD.
Table 1 shows gender-specific, selected cardiovascular
isk factors according to the four categories of walking time
nd sports participation time. Compared with men and
omen who reported 0.5 h/day of walking (second lowest
ategory), those who reported 1.0 h/day of walking
highest category) were more likely to be manual workers,
ave a high dietary intake of fish, participate in sports, and
ere less educated, less likely to have perceived mental
tress, and had little history of hypertension and diabetes
nd a lower mean of body mass index. Men who reported
1.0 h/day of walking smoked, drank more, and slept more,
s compared with those who reported 0.5 h/day of walking.
imilar associations were observed according to sports
articipation categories.
Compared with men and women who reported 0.5 h/day
f walking, those who reported 1.0 h/day walking had a
7% to 33% lower age-adjusted mortality from total stroke,
S, CHD, and total CVD (Table 2). Adjustment for
ardiovascular risk factors somewhat attenuated these rela-
ionships; however, the risk reduction for IS and total CVD
emained statistically significant for men and women com-
ined. The multivariate HR (95% CI) among men and
omen (combined) who reported a walking time of 1.0
ersus 0.5 h/day was 0.71 (0.54 to 0.94), p  0.02 for IS;
.84 (0.64 to 1.09), p  0.19 for CHD; and 0.84 (0.75 to
.95), p  0.006 for total CVD. These inverse associations
ere similarly observed for each gender, although not
tatistically significant in either gender.
Strong inverse associations within the sports participation
ategories were found for mortality from CHD and total
VD (Table 3). The multivariate HR (95% CI) among
en and women who reported time spent participating in
ports for 5 versus 1 to 2 h/week was 0.51 (0.32 to 0.82),
 0.005 for CHD and 0.73 (0.60 to 0.90), p  0.003 for
otal CVD.
We evaluated the HR of death for the lowest versus
econd lowest categories of time spent walking. The mul-
ivariate HR (95% CI) was 1.37 (1.10 to 1.72), p  0.005
or total stroke mortality, and 1.35 (1.16 to 1.57), p  0.001
or total CVD mortality.
These inverse associations for walking and sports partic-
pation time with mortality were not altered substantially
hen deaths occurring within two years after baseline were Ta
b
N
o
P
er A B H H E H C C O M H F S W
T
es
Table 2. Hazard Ratios (95% CI) of Mortality from Cardiovascular Disease According to Walking Time
Walking Time (h/Day)
Men Women Men and Women
<0.5 0.5 0.6–0.9 >1.0 <0.5 0.5 0.6–0.9 >1.10 <0.5 0.5 0.6–0.9 >1.0
Person-yrs 36,354 54,499 56,595 148,929 44,804 71,557 83,491 211,995 81,158 126,056 140,085 360,924
Total stroke
n 70 103 89 237 72 82 76 194 142 185 165 431
Age-adjusted HR 1.24 (0.91–1.68) 1.0 0.76 (0.57–1.01) 0.81 (0.64–1.02) 1.69 (1.23–2.32) 1.0 0.81 (0.59–1.10) 0.87 (0.67–1.13) 1.44 (1.16–1.79) 1.0 0.78 (0.63–0.96) 0.83 (0.70–0.99)
Multivariate HR* 1.15 (0.84–1.57) 1.0 0.79 (0.59–1.05) 0.84 (0.67–1.07) 1.66 (1.20–2.30) 1.0 0.82 (0.60–1.12) 0.93 (0.72–1.21) 1.37 (1.10–1.72) 1.0 0.80 (0.65–0.99) 0.88 (0.74–1.05)
IPH
n 19 29 27 52 17 17 18 40 36 46 45 92
Age-adjusted HR 1.12 (0.63–1.99) 1.0 0.84 (0.50–1.43) 0.64 (0.41–1.00) 1.87 (0.95–3.66) 1.0 0.92 (0.47–1.78) 0.85 (0.48–1.50) 1.39 (0.90–2.15) 1.0 0.87 (0.57–1.31) 0.71 (0.50–1.02)
Multivariate HR* 1.12 (0.62–2.02) 1.0 0.88 (0.52–1.49) 0.73 (0.46–1.16) 1.89 (0.95–3.76) 1.0 0.95 (0.49–1.84) 0.93 (0.52–1.66) 1.38 (0.89–2.15) 1.0 0.90 (0.60–1.37) 0.80 (0.56–1.15)
SAH
n 6 10 7 34 11 15 20 52 17 25 27 86
Age-adjusted HR 0.93 (0.34–2.55) 1.0 0.67 (0.25–1.76) 1.24 (0.61–2.51) 1.32 (0.61–2.87) 1.0 1.14 (0.58–2.23) 1.21 (0.68–2.15) 1.15 (0.62–2.14) 1.0 0.95 (0.55–1.64) 1.21 (0.78–1.89)
Multivariate HR* 0.97 (0.35–2.73) 1.0 0.67 (0.25–1.77) 1.26 (0.61–2.60) 1.40 (0.64–3.08) 1.0 1.08 (0.55–2.11) 1.22 (0.68–2.19) 1.24 (0.66–2.31) 1.0 0.93 (0.54–1.61) 1.25 (0.80–1.97)
Ischemic stroke
n 26 45 28 87 26 34 21 60 52 79 49 147
Age-adjusted HR 1.12 (0.69–1.81) 1.0 0.54 (0.33–0.86) 0.67 (0.47–0.96) 1.53 (0.92–2.55) 1.0 0.54 (0.32–0.94) 0.67 (0.44–1.03) 1.30 (0.92–1.85) 1.0 0.54 (0.38–0.76) 0.67 (0.51–0.88)
Multivariate HR* 1.03 (0.63–1.69) 1.0 0.56 (0.35–0.91) 0.71 (0.49–1.02) 1.38 (0.82–2.33) 1.0 0.56 (0.32–0.97) 0.73 (0.48–1.13) 1.18 (0.82–1.69) 1.0 0.56 (0.39–0.80) 0.71 (0.54–0.94)
CHD
n 39 48 48 109 21 36 34 62 60 84 82 171
Age-adjusted HR 1.45 (0.95–2.22) 1.0 0.89 (0.60–1.33) 0.80 (0.57–1.13) 1.12 (0.66–1.93) 1.0 0.82 (0.52–1.32) 0.64 (0.42–0.97) 1.32 (0.95–1.84) 1.0 0.85 (0.63–1.16) 0.73 (0.56–0.95)
Multivariate HR* 1.56 (1.01–2.41) 1.0 0.91 (0.61–1.36) 0.93 (0.66–1.32) 1.04 (0.60–1.80) 1.0 0.82 (0.51–1.32) 0.74 (0.49–1.13) 1.34 (0.96–1.89) 1.0 0.89 (0.65–1.21) 0.84 (0.64–1.09)
Total CVD
n 155 225 202 499 145 176 173 371 300 401 375 870
Age-adjusted HR 1.24 (1.01–1.52) 1.0 0.79 (0.66–0.96) 0.78 (0.67–0.92) 1.59 (1.28–1.99) 1.0 0.86 (0.70–1.06) 0.79 (0.66–0.94) 1.40 (1.20–1.62) 1.0 0.82 (0.71–0.94) 0.78 (0.69–0.88)
Multivariate HR* 1.21 (0.98–1.49) 1.0 0.83 (0.68–1.00) 0.85 (0.72–1.00) 1.50 (1.20–1.87) 1.0 0.87 (0.70–1.07) 0.85 (0.70–1.02) 1.35 (1.16–1.57) 1.0 0.85 (0.74–0.98) 0.84 (0.75–0.95)
*Adjusted for age, gender, sports time, and cardiovascular risk factors.
CHD  coronary heart disease; CI  confidence interval; CVD  cardiovascular disease; HR  hazard ratios; IPH  intraparenchymal hemorrhage; SAH  subarachnoid hemorrhage.
1764
Noda
etal.
JACC
Vol.46,No.9,2005
Exercise
and
Cardiovascular
Disease
Novem
ber1,2005:1761–7
Table 3. Hazard Ratios (95% CI) of Mortality from Cardiovascular Disease According to Sports Time
Sports Time (h/Week)
Men Women Men and Women
<1 1–2 3–4 >5 <1 1–2 3–4 >5 <1 1–2 3–4 >5
Person-yrs 201,833 50,934 20,946 22,663 311,184 58,081 22,287 20,294 513,017 109,015 43,233 42,958
Total stroke
n 337 70 46 46 317 61 25 21 654 131 71 67
Age-adjusted HR 1.37 (1.06–1.77) 1.0 1.17 (0.80–1.70) 0.88 (0.60–1.27) 1.04 (0.79–1.37) 1.0 0.79 (0.50–1.26) 0.60 (0.36–0.98) 1.23 (1.02–1.48) 1.0 1.00 (0.75–1.33) 0.75 (0.56–1.01)
Multivariate HR* 1.26 (0.97–1.64) 1.0 1.17 (0.81–1.71) 0.87 (0.59–1.27) 0.88 (0.67–1.17) 1.0 0.79 (0.49–1.26) 0.57 (0.35–0.95) 1.09 (0.90–1.32) 1.0 1.01 (0.76–1.35) 0.75 (0.55–1.01)
IPH
n 91 17 12 7 72 13 4 3 163 30 16 10
Age-adjusted HR 1.42 (0.85–2.39) 1.0 1.36 (0.65–2.84) 0.61 (0.25–1.48) 1.10 (0.61–1.98) 1.0 0.63 (0.20–1.92) 0.44 (0.12–1.53) 1.29 (0.88–1.91) 1.0 1.05 (0.57–1.92) 0.53 (0.26–1.09)
Multivariate HR* 1.41 (0.83–2.40) 1.0 1.41 (0.67–2.97) 0.67 (0.27–1.64) 0.84 (0.46–1.55) 1.0 0.61 (0.20–1.87) 0.40 (0.11–1.41) 1.17 (0.78–1.74) 1.0 1.08 (0.59–1.99) 0.56 (0.27–1.16)
SAH
n 34 14 4 5 67 17 10 4 101 31 14 9
Age-adjusted HR 0.60 (0.32–1.13) 1.0 0.66 (0.22–2.02) 0.71 (0.25–1.98) 0.78 (0.46–1.32) 1.0 1.29 (0.59–2.81) 0.49 (0.16–1.45) 0.70 (0.47–1.05) 1.0 0.99 (0.53–1.86) 0.57 (0.27–1.21)
Multivariate HR* 0.56 (0.30–1.07) 1.0 0.66 (0.22–2.03) 0.65 (0.23–1.85) 0.70 (0.41–1.21) 1.0 1.23 (0.56–2.70) 0.45 (0.15–1.36) 0.64 (0.43–0.97) 1.0 0.95 (0.51–1.80) 0.53 (0.25–1.12)
Ischemic stroke
n 126 25 18 17 109 18 6 8 235 43 24 25
Age-adjusted HR 1.50 (0.97–2.30) 1.0 1.21 (0.66–2.22) 0.84 (0.45–1.55) 1.23 (0.75–2.03) 1.0 0.61 (0.24–1.53) 0.71 (0.31–1.62) 1.41 (1.02–1.96) 1.0 0.97 (0.59–1.60) 0.78 (0.47–1.27)
Multivariate HR* 1.34 (0.86–2.08) 1.0 1.22 (0.66–2.25) 0.84 (0.45–1.57) 1.07 (0.64–1.77) 1.0 0.62 (0.25–1.58) 0.73 (0.31–1.70) 1.26 (0.90–1.75) 1.0 1.00 (0.61–1.66) 0.80 (0.48–1.31)
CHD
n 153 49 22 20 118 23 8 4 271 72 30 24
Age-adjusted HR 0.88 (0.64–1.21) 1.0 0.83 (0.50–1.37) 0.57 (0.34–0.96) 1.04 (0.67–1.63) 1.0 0.67 (0.30–1.49) 0.30 (0.10–0.86) 0.95 (0.73–1.23) 1.0 0.77 (0.50–1.18) 0.49 (0.31–0.78)
Multivariate HR* 0.84 (0.60–1.17) 1.0 0.86 (0.52–1.43) 0.60 (0.36–1.03) 0.91 (0.58–1.44) 1.0 0.71 (0.31–1.59) 0.30 (0.10–0.87) 0.89 (0.68–1.16) 1.0 0.80 (0.52–1.22) 0.51 (0.32–0.82)
Total CVD
n 720 183 87 91 660 107 49 49 1380 290 136 140
Age-adjusted HR 1.11 (0.94–1.30) 1.0 0.86 (0.66–1.11) 0.68 (0.53–0.87) 1.24 (1.01–1.52) 1.0 0.88 (0.63–1.23) 0.78 (0.56–1.10) 1.18 (1.04–1.33) 1.0 0.86 (0.70–1.06) 0.71 (0.58–0.87)
Multivariate HR* 1.05 (0.89–1.24) 1.0 0.87 (0.67–1.12) 0.70 (0.54–0.90) 1.09 (0.88–1.34) 1.0 0.89 (0.63–1.25) 0.81 (0.57–1.14) 1.07 (0.94–1.22) 1.0 0.88 (0.72–1.08) 0.73 (0.60–0.90)
*Adjusted for age, gender, walking time, and cardiovascular risk factors.
Abbreviations as in Table 2.
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mong men and women (combined) for time spent walking
or1.0 versus 0.5 h/day was 0.73 (0.54 to 0.97), p 0.032
or mortality due to IS; 0.85 (0.64 to 1.13), p  0.263, for
HD; and 0.87 (0.76 to 0.99), p  0.028 for total CVD.
he multivariate HR (95% CI) among men and women
combined) for time spent participating in sports for 5
ersus 1 to 2 h/week was 0.47 (0.28 to 0.78), p  0.004 for
ortality due to CHD and 0.78 (0.63 to 0.97), p 0.03 for
otal CVD mortality.
ISCUSSION
n the present large prospective study of Japanese men and
omen, we observed approximately a 20% to 50% reduction
n mortality due to IS, CHD, and total CVD associated
ith higher physical activity through walking and sports
articipation. These relationships were not substantially
ltered after adjustment for known risk factors or when
eaths that occurred within two years were excluded from
he analysis.
Our findings are consistent with previous reports of
mericans (1,2,5,6), Japanese-Americans (4,7), and Euro-
eans (3) and meta-analyses (18,19). Total physical activity
21.7 vs. 0 to 2.0 MET-h/week), physical activity through
alking (10 vs. 0.5 MET-h/week), and walking pace
3 vs. 2 mph) were associated with 34%, 35%, and 36%
espective reductions in the risk of developing CHD (1),
nd 48%, 40%, and 53% respective reductions in risk of IS
5) for American nurses. Similar risk reductions (approxi-
ately 30% to 50%) for CHD (3,4) and IS (7) associated
ith walking and leisure-time physical activity were found
or Japanese-American men and European men. In previous
eta-analyses, high activity and moderate activity were
ssociated with 37% and 10% respective risk reduction of
ortality from CHD (18), and high activity and moderate
ctivity were associated with 21% and 9% respective risk
eduction of incidence or mortality from IS (19), compared
ith low activity.
We did not find any significant inverse association
etween physical activity and mortality from IPH or SAH.
his finding is consistent with the results of studies exam-
ning American nurses (5) but not of American male
hysicians (6) and Japanese-American men (7). American
ale physicians (6) who exercised 5 versus 1 time/week
ad a 46% lower risk for hemorrhagic stroke, but this
ssociation was observed only among subjects ages 55 to 68
ears but not for those 40 to 54 years of age. Japanese-
merican men who were physically active had a 73% lower
isk of hemorrhagic stroke mortality (7), compared with
on-active men.
Furthermore, our data suggest a potential differential
ffect of walking versus sports participation on IS and CHD
isk. We found that participation in sports was associated
ith a reduced mortality due to CHD, but this association
id not exist with walking time. Walking time, however, sas associated with a reduced risk for mortality from IS, but
ports participation was not. A similar pattern of association
etween physical activity and CHD was observed in previ-
us studies (2,3). In a study of American male health
rofessionals (2), average exercise intensity was associated
ith reduced risk of CHD, independent of total physical
ctivity. In European men (3), energy expenditure during
ngagement in leisure-time physical activity was associated
ith a lower risk of CHD, whereas walking or cycling to
ork was not. A reason for reduced mortality from IS by
alking but not by sports participation in our study is
ncertain. One of the potential mechanisms for the differ-
ntial association might be a differential effect of physical
ctivity intensity on insulin resistance. Reduced insulin
esistance by moderate-intensity exercise was larger than by
igh-intensity exercise, when the amount of physical activ-
ty was not large (11). Insulin resistance raises the risk of IS
ore than that of CHD (20,21). Therefore, moderate
ntensity physical activity similar to walking (17) is more
ikely to improve insulin resistance and might reduce the
isk of IS to a greater degree than the risk of CHD.
Common mechanisms for a reduced risk of IS and CHD
ssociated with walking or sports participation include
mproved endothelial function (13), an increase in HDL-
holesterol levels (12), and the lowering of ambulatory
lood pressure through decreased sympathetic nervous ac-
ivity (8,9). Previous cohort studies revealed that glucose
ntolerance (22,23), low HDL-cholesterol levels (24,25),
nd high blood pressure (26, 27) raised the risk of IS and
HD, and in hypertensive patients, endothelial dysfunction
aised the risk of cardiovascular events (28). In the present
tudy, the prevalence of a history of hypertension and
iabetes was lower for subjects of both genders who spent
ore time walking or participating in sports.
Limitations of the present study included the fact that we
id not have systematic information on pre-clinical disor-
ers that prevented the participants from walking or partic-
pating in sports. This might have lead to a bias of
ause-effect reversal, even though most of the subjects were
pparently healthy. To avoid the potential bias due to
re-clinical disorders and/or psychosocial distress, we chose
he second lowest physical activity categories as a reference.
n fact, persons with the lowest categories of physical
ctivity were more overweight, drank more, were more
entally stressed, and less educated. This probably leads to
n underestimate of HRs. We also repeated the data
nalysis by excluding early deaths, which would also reduce
he potential confounding effect of pre-clinical disorders.
A second limitation of the current study was that we did
ot have incidence data. We used the death certificate and
id not validate causes of death; however, previous studies
ave shown that death certificate diagnosis with regard to
troke subtypes is valid, owing to the high prevalence of CT
can or MRI use in hospitals in Japan (29,30).
The strength of the present study is a statistical power
ufficient to detect the effects of physical activity on mor-
t
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November 1, 2005:1761–7 Exercise and Cardiovascular Diseaseality from CVD. We found a significant inverse association
etween time spent walking and the risk of IS in addition to
n inverse relationship between sports participation and risk
f CHD in Asian countries, where job-related physical
ctivity is generally higher than in Western countries (14).
In conclusion, the present study provides epidemiological
vidence that engaging in physical activity through walking
nd sports participation might reduce risk of mortality from
S and CHD among Japanese men and women.
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